Shown: posts 1 to 2 of 2. This is the beginning of the thread.
Posted by Dr. Bob on October 13, 2002, at 1:43:02
[Posted by chad_3 on October 13, 2002, at 0:38:41]
> Br J Nurs 2002 Mar 28-Apr 10;11(6):374-8 Related Articles, Links
>
>
> Development of a screening tool to assess risk of tardive dyskinesia.
>
> Taylor J.
>
> Black Country Mental Health NHS Trust.
>
> This article gives an overview of antipsychotic medication and of tardive dyskinesia (TD). It examines the research available on TD as it relates to people with a learning disability (PWLD). The evidence identifies that specific groups of people are at an increased risk of developing TD. It also shows that 45-50% of PWLD who are treated with antipsychotic medication will be affected by TD. The evidence is used in the formulation of an assessment tool designed for use by the community learning disability nurse to identify an individual's risk of developing TD before commencing medication. Litigation in the USA has led to a $6.7 m award for sound, clinically effective practice and evidence-based interventions requires that practitioners are accountable for their practice, but are also seen to transform existing services in a way which improves the delivery of quality interventions and care.
>
> PMID: 11979217 [PubMed - indexed for MEDLINE]
>
>
> Chad
>
Posted by chad_3 on October 13, 2002, at 11:46:11
In reply to 50% Tardive Risk with Learning Disability « chad_3, posted by Dr. Bob on October 13, 2002, at 1:43:02
Thanks Dr. Bob:
I couldn't find post where I placed it so thought it was gone - now I see it here...
> [Posted by chad_3 on October 13, 2002, at 0:38:41]
>
> > Br J Nurs 2002 Mar 28-Apr 10;11(6):374-8 Related Articles, Links
> >
> >
> > Development of a screening tool to assess risk of tardive dyskinesia.
> >
> > Taylor J.
> >
> > Black Country Mental Health NHS Trust.
> >
> > This article gives an overview of antipsychotic medication and of tardive dyskinesia (TD). It examines the research available on TD as it relates to people with a learning disability (PWLD). The evidence identifies that specific groups of people are at an increased risk of developing TD. It also shows that 45-50% of PWLD who are treated with antipsychotic medication will be affected by TD. The evidence is used in the formulation of an assessment tool designed for use by the community learning disability nurse to identify an individual's risk of developing TD before commencing medication. Litigation in the USA has led to a $6.7 m award for sound, clinically effective practice and evidence-based interventions requires that practitioners are accountable for their practice, but are also seen to transform existing services in a way which improves the delivery of quality interventions and care.
> >
> > PMID: 11979217 [PubMed - indexed for MEDLINE]
> >
> >
> > Chad
> >
>
>
This is the end of the thread.
Psycho-Babble Medication | Extras | FAQ
Dr. Bob is Robert Hsiung, MD,
bob@dr-bob.org
Script revised: February 4, 2008
URL: http://www.dr-bob.org/cgi-bin/pb/mget.pl
Copyright 2006-17 Robert Hsiung.
Owned and operated by Dr. Bob LLC and not the University of Chicago.